Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The war is far from over but Ukraine’s government is already considering how to build back — and use the opportunity to move on from a Soviet-era system.
When researchers spotted clues that trees were growing to record heights in the rainforest, they tried, failed and tried again to reach the remote site.
The FDA’s decision, expected this month, follows several setbacks and delays and will pose difficult choices for the families of children with Duchenne muscular dystrophy.
Shocked by the COVID-19 infodemic, several efforts have launched to gather researchers’ consensus views, with the hope of improving public debate and policymaking.
Despite broader acceptance of neurodiversity, autistic advocates and scientists are still fighting for a chance to set clinical and scientific priorities.
The most popular repository for sharing SARS-CoV-2 sequence data has come under increasing scrutiny. Scientists and funders around the world must now consider what lies ahead for the open sharing of genome data.
The current landscape of mobile mental-health apps is the result of a 70-year search to automate therapy. Now, advanced AIs pose fresh ethical questions.
Perceptions have shifted dramatically in the past few years on the therapeutic value of illicit drugs such as ecstasy. But questions still linger about what FDA approval might look like.
A raft of commercial lunar missions are taking off in 2023. The first lander is set to touch down this month, signalling a new era for Moon science and exploration.